Altre lingue Dr. Lal PathLabs Limited

Azioni

LALPATHLAB

INE600L01024

Prestatari di assistenza sanitaria

Tempo differito NSE India S.E. Altri mercati azionari 08:26:49 24/06/2025			Variaz. 5gg	Var. 1 gen.
2.812,00 ^INR	+0,29%		-3,97%	-6,28%

28/04	DR. LAL PATHLABS LIMITED : Nomura è per il Buy	ZM
25/04	Dr. Lal PathLabs Limited, Q4 2025 Earnings Call, Apr 25, 2025

Altre lingue

Dr. Lal PathLabs Records Growth in Fiscal Q4 Consolidated Profit	28/04
India's Dr Lal Path Labs beats quarterly profit view on medical testing boom	25/04
Dr. Lal Pathlabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025, Payable on or Before July 27, 2025	25/04
Dr. Lal PathLabs Limited Reports Earnings Results for the Full Year Ended March 31, 2025	25/04
Dr. Lal PathLabs Launches South Asia's First Test for Amyloid Protein Typing	15/04
Dr. Lal Pathlabs Launches Advanced Test For Amyloidosis	15/04
Dr. Lal Pathlabs Limited Launches Advanced Test for Amyloidosis	15/04
Dr. Lal PathLabs Arm Gets Members' Nod for Voluntary Liquidation	07/02
India's Dr Lal Path Labs posts higher Q3 profit on steady testing demand	30/01
Dr. Lal Pathlabs Limited Approves Declaration Third Interim Dividend for Financial Year 2024-25	30/01
Dr. Lal PathLabs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	30/01
Antara Partners with Dr. Lal Pathlabs to Strengthen Its Geriatric Care Services	19/12
Dr. Lal PathLabs' Fiscal Q2 Profit Rises, EPS Beats Estimates; Shares Down 5%	24/10/24
India's Dr Lal Path Labs posts bigger-than-expected Q2 profit on demand for medical tests	23/10/24
Dr. Lal PathLabs Limited Approves Second Interim Dividend for the Financial Year 2024 - 2025	23/10/24
Dr. Lal Pathlabs Limited Announces Stepping Down of Dr. Om Prakash Manchanda as Managing Director, Effective March 31, 2025	23/10/24
Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	23/10/24
Dr. Lal PathLabs' Consolidated Net Profit Shows Growth in Fiscal Q1	08/08/24
India's Dr Lal PathLabs tops Q1 profit estimates on strong testing demand	07/08/24
Dr. Lal PathLabs Limited Approves Interim Dividend for the Fiscal Year 2024-25	07/08/24
Dr. Lal PathLabs Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	07/08/24
Dr. Lal PathLabs Limited Declares Final Dividend for the Financial Year Ended March 31, 2024	29/06/24
Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6%	13/05/24
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand	10/05/24
Dr. Lal PathLabs Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024	10/05/24

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Dr. Lal PathLabs Limited

Azioni

LALPATHLAB

INE600L01024

Prestatari di assistenza sanitaria

Altre lingue

Filtri